Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
2
×
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
10x genomics
abbvie
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
biogen
boston
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
centers for disease control and prevention
chinook therapeutics
clostridium difficile
community-acquired bacterial pneumonia
crispr
cynthia collins
dana hilt
daprodustat
david chacko
david marek
detroit blog main
detroit top stories
drugs
duchenne muscular dystrophy
editas medicine
eli lilly
What
regulatory
2
×
allergan
august
bio
biotech
blessing
bosley
busy
ceo
check
clinical
crispr
cusp
days
decisions
depart
devices
drugs
editas
editing
experimental
fda
gene
humans
katrine
legacy
medicine
million
news
nods
opioid
partner
past
roundup
sarepta’s
seven
shkreli’s
slow
stumble
suits
Language
unset
Current search:
regulatory
×
allergan
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial